Coherus BioSciences
NASDAQ: CHRS
NYSE
NYSE
Healthcare
Biotechnology
Global Rank
#24616
Country Rank
#3541
Market Cap
96.22 M
Price
0.83
Change (%)
3.02%
Volume
1.87 M
Coherus BioSciences's latest marketcap:
96.22 M
As of 06/08/2025, Coherus BioSciences's market capitalization has reached $96.22 M. According to our data, Coherus BioSciences is the 24616th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 96.22 M |
| Revenue (ttm) | 272.25 M |
| Net Income (ttm) | -130,937,000 |
| Shares Out | 115.93 M |
| EPS (ttm) | -1.14 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/12/2025 |
Market Cap Chart
Data Updated: 06/08/2025
Coherus BioSciences's yearly market capitalization.
Coherus BioSciences has seen its market value drop from $542.8 M to $96.22 M since 2014, representing a total decrease of 82.27% and an annual compound decline rate (CAGR) of 15.27%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/08/2025 | $96.22 M | -39.5% |
| 12/31/2024 | $159 M | -57.12% |
| 12/29/2023 | $370.8 M | -39.81% |
| 12/30/2022 | $616 M | -49.73% |
| 12/31/2021 | $1.23 B | -2.13% |
| 12/31/2020 | $1.25 B | -0.83% |
| 12/31/2019 | $1.26 B | 105.12% |
| 12/31/2018 | $615.6 M | 20.73% |
| 12/29/2017 | $509.9 M | -58.5% |
| 12/30/2016 | $1.23 B | 37.6% |
Company Profile
Coherus BioSciences was founded in 2010 in United States.
The company went public on 11/06/2014
on the Nasdaq Stock Market.
With 228 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is Coherus BioSciences's (CHRS) current market cap?As of 06/08/2025, Coherus BioSciences (including the parent company, if applicable) has an estimated market capitalization of $96.22 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Coherus BioSciences (CHRS) rank globally by market cap?Coherus BioSciences global market capitalization ranking is approximately 24616 as of 06/08/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.